Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer

Laryngoscope

Volumn 123, Issue 1, 2013, Pages 152-157

  Chen, Allen M ^a   Li, Judy ^b   Beckett, Laurel A ^b   Zhara, Talia ^a   Farwell, Gregory ^a   Lau, Derick H ^b   Gandour Edwards, Regina ^b   Vaughan, Andrew T ^a   Purdy, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

head and neck cancer; Human papillomavirus; Level of Evidence: 3B; radiation therapy; radiosensitivity; squamous cell carcinoma

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MATHEMATICAL MODEL; MULTIPLE CYCLE TREATMENT; OBSERVATIONAL STUDY; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; TUMOR REGRESSION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; CONE-BEAM COMPUTED TOMOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 84871716229     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23570     Document Type: Article

References (24)

1. Gillison ML, D'Souza G, Westra WH, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008: 100: 407-420.
2. Braakhuis BJ, Snijders PJ, Keune WH, et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2005; 96: 998-1006.
3. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirusa-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747.
4. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
5. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
6. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal sqamous cell carcinoma. J Clin Oncol 2006; 24: 5630-5636.
7. Lindel K, Beer KT, Laissure J, et al. Human papillomavirus in positive squamous cell carcinoma of the oropharynx. Cancer 2001; 92: 805-813.
8. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV titer, bcl-xL, and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008; 26: 3128-3137.
9. Lassen P, Eriksen JG, Hamilton S, et al. Effect of HPV-associated p16 expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009; 27: 1992-1998.
10. Singhi AD, and, Westra WH,. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010; 116: 2166-2173.
11. Perks JR, Lehmann J, Chen AM, et al. Comparison of peripheral dose fro image-guided radiation therapy (IGRT) using kV cone beam CT to intensity-modulated radiation therapy (IMRT). Radiother Oncol 2008; 89: 304-310.
12. Spanos WC, Nowicki P, Lee DW, et al. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol Head Neck Surg 2009; 135: 1137-1146.
13. Williams R, Lee DW, Elzey BD, et al. Preclinical models of HPV-positive and HPV-negative HNSCC in mice: an immune clearance of HPV-positive HNSCC. Head Neck 2009; 31: 911-918.
14. Kong CS, Narasimhan B, Cao H, et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2009; 74: 553-561.
15. Ragin CC, Taioli E,. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121: 1813-1820.
16. Zheng Y, Zhang J, Rao Z,. Ribozyme targeting HPV16 E6E7 transcripts in cervical cancer cells suppresses cell growth and sensitizes cells to chemotherapy and radiotherapy. Cancer Biol Ther 2004; 3: 1129-1134.
17. Hampson ES, Hady EI, Moore JV, et al. The HPV16 E6 and E7 proteins and the radiation resistance of cervical carcinoma. FASEB J 2001; 15: 1445-1447.
18. DeWeese TL, Walsh JC, Dillehay LE, et al. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation. Int J Radiat Oncol Biol Phys 1997; 37: 145-154.
19. Gupta AK, Lee JH, Wilke WW, et al. Radiation response in two HPV-infected head and neck cancer cell lines in comparison to non-HPV-infected cell line and relationship to signaling through AKT. Int J Radiat Oncol Biol Phys 2009; 74: 928-933.
20. Klussmann JP, Mooren JJ, Lehnen M, et al. Genetic signatures of HPV-related and unrelated oropharygneal carcinoma and their prognostic implications. Clin Cancer Res 2009; 15: 1179-1786.
21. Kim JY, Park S, Nam BH, et al. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy. J Clin Oncol 2009; 27: 5088-5093.
22. Lomard I, Vincent-Salomon A, Validire P, et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol 1998; 16: 2613-2619.
23. Harima Y, Sawada S, Nagata K, et al. Human papillomavirus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2002; 52: 1345-1351.
24. Higgins GD, Davy M, Roder D, et al. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 1991; 338: 910-913.